期刊文献+

分化型甲状腺癌患者术后放射性^(131)I治疗效果的影响因素分析 被引量:12

Analysis of Factors Influencing the Efficacy of Radioactive ^(131)I in the Treatment of Patients with Differentiated Thyroid Carcinoma after Operation
下载PDF
导出
摘要 目的探讨分化型甲状腺癌(DTC)患者术后放射性^(131)I治疗效果的影响因素。方法选取115例手术后首次行^(131)I治疗的DTC患者作为研究对象,根据治疗后^(131)I全身显影结果将其分为清甲成功组与清甲未成功组,前者完全清除残余甲状腺组织,后者未完全清除残余甲状腺组织。影响因素分析先采用χ~2检验进行单因素分析,然后选择有统计学意义的指标进行非条件logistic回归分析。结果 115例DTC患者,其中51例患者在术后经首次^(131)I治疗即成功清除残余甲状腺组织,治疗成功率为44.3%。清甲成功组与清甲未成功组性别、年龄、体质指数(BMI)、病理类型差异无统计学意义(P>0.05),2组患者手术方式、^(131)I首次治疗剂量、^(131)I首次治疗前促甲状腺激素(TSH)以及甲状腺球蛋白(Tg)水平差异有统计学意义(P<0.05)。多因素非条件Logistic回归分析显示:^(131)I首次治疗剂量、^(131)I首次治疗前TSH以及Tg水平等指标是影响DTC患者术后放射性^(131)I治疗效果的独立相关因素(P<0.05),手术方式是非独立相关因素(P>0.05)。结论^(131)I首次治疗剂量、^(131)I首次治疗前TSH以及Tg水平是影响DTC患者术后放射性^(131)I治疗效果的重要因素。 Objective To explore the factors influencing the efficacy of radioactive 131I in the treatment of patients with differentiated thyroid carcinoma(DTC) after operation. Methods 115 cases of DTC who was given initial 131I therapy after oper- ation were were divided into ablation successful group and ablation unsuccessful group according to the result of 131I whole body imaging, and the residual thyroid tissues in ablation successful group were ablated completely, while ablation unsuccessful group were ablated incompletely. The influencing factors were analyzed by X2 test firstly, then these statistically significant indicators were analyzed by multivariate non-conditioned logistic regression analysis. Results There were 51 cases of patients succeeded in removing thyroid remnant tissue after initial 131I therapy among the 115 cases of DTC, and the success rate was 44.3%. There were no obvious differences in gender, age, body mass index (BMI), pathological type between ablation successful group and abla- tion unsuccessful group (P 〉 0.05 ), while obvious differences were found in surgical method, initial therapeutic dose of 131I, levels of thyroid stimulating hormone (TSH) and thyroid globulin (Tg) before initial 131I therapy between the 2 groups(P 〈0.05). Multivariate non-conditioned logistic regression analysis showed that initial therapeutic dose of 131I, levels of TSH and Tg before initial 13~ I therapy were dependent relevant factors influencing the efficacy of radioactive 131I in the treatment of patients with DTC after operation ( P 〈 0.05 ), while surgical method was independent relevant factor ( P 〉 0.05 ). Conclusion The initial therapeu- tic dose of 131I ,levels of TSH and Tg before initial 131I therapy are important factors influencing the efficacy of radioactive 131I in the treatment of patients with DTC after operation.
出处 《实用癌症杂志》 2016年第9期1528-1530,共3页 The Practical Journal of Cancer
关键词 分化型甲状腺癌 放射性(131)I 促甲状腺激素 甲状腺球蛋白 Differentiated thyroid carcinoma Radioactive 131I Tthyroid stimulating hormone Thyroid globulin
  • 相关文献

参考文献8

二级参考文献56

  • 1刘光俊.甲状腺癌骨转移的影像学诊断[J].第一军医大学学报,2004,24(8):920-921. 被引量:6
  • 2陈福进,李秋梨,曾宗渊,宋明,杨安奎,张诠.分化型甲状腺癌的治疗及影响复发的因素分析[J].癌症,2004,23(11):1311-1316. 被引量:50
  • 3金文昊,李瑞永,金哲洙,李学哲.分化型甲状腺癌骨转移临床分析[J].中国肿瘤临床,2004,31(24):1389-1391. 被引量:9
  • 4Zanotti-Fregonara P, Rubello D, Hindie E. Metastases of differentiated thyroid cancer: the importance of early diagnosis and :3q therapy on prognosis. J Nucl Med, 2008, 49: 1902-1903.
  • 5Nemec j, Zamrazil V, Pohunkova D, et al. Mode of spread of the thyroid cancer. Oncology, 1979, 36: 232-235.
  • 6Orita Y, Sugitani I, Matsuura M, et al. Prognostic factors and the therapeutic strategy for patients with bone metastasis from differentiated thyroid carcinoma. Surgery, 2010, 147:424-431.
  • 7Rosario PW, Borges MA, Purisch S. Preparation with recombinant human thyroid-stimulating hormone for thyroid remnant ablation with ^131I is associated with lowered radiotoxicity. J Nucl Med, 2008,49(11 ) : 1776-1782.
  • 8Dos SSI,Swerdlow AJ. Thyroid cancer epidemiology in England and Wales: time trends and geographical distribution. Br J Cancer, 1993,67(2) : 330-340.
  • 9Pettersson B,Adami HO,Wilander E,et al. Trends in thyroid cancer incidence in Sweden, 1958-1981 ,by histopathologic type. Int J Cancer, 1991,48(1) :28-33.
  • 10Woodrum DT,Ganger PG. Role of ^131I in the treatment of well differentiated thyroid cancer. J Surg Oncol,2005,89(3):114- 121.

共引文献77

同被引文献116

引证文献12

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部